ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

Molecular glue degraders offer a new approach to lymphoma therapy by targeting cancer proteins for destruction. The strategy aims to treat lymphoma through a distinct mechanism from conventional cancer drugs.
Tap to vote and see what everyone thinks.
Summary by ByteBrief